These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1190 related articles for article (PubMed ID: 11274346)

  • 21. Signals that initiate myelination in the developing mammalian nervous system.
    Colello RJ; Pott U
    Mol Neurobiol; 1997 Aug; 15(1):83-100. PubMed ID: 9396006
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myelination of the nervous system: mechanisms and functions.
    Nave KA; Werner HB
    Annu Rev Cell Dev Biol; 2014; 30():503-33. PubMed ID: 25288117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The myelin-deficient rat mutant: partial recovery of oligodendrocyte maturation in vitro.
    Espinosa de los Monteros A; Zhang M; Gordon MN; Kumar S; Scully SA; de Vellis J
    Dev Neurosci; 1990; 12(4-5):326-39. PubMed ID: 2289414
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transcriptional and post-transcriptional control of CNS myelination.
    Emery B
    Curr Opin Neurobiol; 2010 Oct; 20(5):601-7. PubMed ID: 20558055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of adult oligodendrocytes in remyelination after neural injury.
    Vick RS; Neuberger TJ; DeVries GH
    J Neurotrauma; 1992 Mar; 9 Suppl 1():S93-103. PubMed ID: 1588636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurite outgrowth inhibitor Nogo-A establishes spatial segregation and extent of oligodendrocyte myelination.
    Chong SY; Rosenberg SS; Fancy SP; Zhao C; Shen YA; Hahn AT; McGee AW; Xu X; Zheng B; Zhang LI; Rowitch DH; Franklin RJ; Lu QR; Chan JR
    Proc Natl Acad Sci U S A; 2012 Jan; 109(4):1299-304. PubMed ID: 22160722
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oligodendrocyte development and differentiation in the rumpshaker mutation.
    Fanarraga ML; Sommer IU; Griffiths IR; Montague P; Groome NP; Nave KA; Schneider A; Brophy PJ; Kennedy PG
    Glia; 1993 Oct; 9(2):146-56. PubMed ID: 7503954
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transgenic mice expressing polyoma virus large T antigen in astrocytes develop severe dysmyelination of the central nervous system.
    Baron-Van Evercooren A; Jensen NA; Wyss MT; Cuzin F; Rassoulzadegan M; Brucher JM; Baron H
    Lab Invest; 1992 Jan; 66(1):39-53. PubMed ID: 1309929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myelin and disorders that affect the formation and maintenance of this sheath.
    Porter BE; Tennekoon G
    Ment Retard Dev Disabil Res Rev; 2000; 6(1):47-58. PubMed ID: 10899797
    [No Abstract]   [Full Text] [Related]  

  • 30. Injury-related dynamic myelin/oligodendrocyte axon-outgrowth inhibition in the central nervous system.
    Schwab JM; Failli V; Chédotal A
    Lancet; 2005 Jun 11-17; 365(9476):2055-7. PubMed ID: 15950719
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myelin proteolipid proteins promote the interaction of oligodendrocytes and axons.
    Yool DA; Klugmann M; McLaughlin M; Vouyiouklis DA; Dimou L; Barrie JA; McCulloch MC; Nave KA; Griffiths IR
    J Neurosci Res; 2001 Jan; 63(2):151-64. PubMed ID: 11169625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myelin in the Central Nervous System: Structure, Function, and Pathology.
    Stadelmann C; Timmler S; Barrantes-Freer A; Simons M
    Physiol Rev; 2019 Jul; 99(3):1381-1431. PubMed ID: 31066630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Many naturally occurring mutations of myelin proteolipid protein impair its intracellular transport.
    Gow A; Friedrich VL; Lazzarini RA
    J Neurosci Res; 1994 Apr; 37(5):574-83. PubMed ID: 7518006
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myelin restoration: progress and prospects for human cell replacement therapies.
    Potter GB; Rowitch DH; Petryniak MA
    Arch Immunol Ther Exp (Warsz); 2011 Jun; 59(3):179-93. PubMed ID: 21461592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prolonged Sox4 expression in oligodendrocytes interferes with normal myelination in the central nervous system.
    Potzner MR; Griffel C; Lütjen-Drecoll E; Bösl MR; Wegner M; Sock E
    Mol Cell Biol; 2007 Aug; 27(15):5316-26. PubMed ID: 17515609
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunoglobulins promote remyelination in the central nervous system.
    Rodriguez M; Lennon VA
    Ann Neurol; 1990 Jan; 27(1):12-7. PubMed ID: 2301922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Repairing CNS myelin--astrocytes have to do their jobs.
    Aldskogius H
    Exp Neurol; 2005 Mar; 192(1):7-10. PubMed ID: 15698614
    [No Abstract]   [Full Text] [Related]  

  • 38. Myelin mutants: model systems for the study of normal and abnormal myelination.
    Griffiths IR
    Bioessays; 1996 Oct; 18(10):789-97. PubMed ID: 8885716
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Do oligodendrocytes divide?
    Norton WT
    Neurochem Res; 1996 Apr; 21(4):495-503. PubMed ID: 8734444
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The response of oligodendrocytes to chemical injury.
    Blakemore WF
    Acta Neurol Scand Suppl; 1984; 100():33-8. PubMed ID: 6385605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 60.